Evidence map›Paper›PMID 34795799›Full record

ArticleEFSA journal. European Food Safety Authority2021

Modification of the existing maximum residue levels for fosetyl/phosphonic acid in citrus fruits resulting from the use of potassium phosphonates.

EFSA (European Food Safety Authority), Giulia Bellisai, Giovanni Bernasconi, Alba Brancato, Luis Carrasco Cabrera, Lucien Ferreira, German Giner, Luna Greco, Samira Jarrah, Aija Kazocina and 12 more

Open access · diamondAbstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Scientific statement on the maximum residue levels for potassium phosphonates.EFSA journal. European Food Safety Authority · 2022
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

EFSA (European Food Safety Authority)
Giulia Bellisai
Giovanni Bernasconi
Alba Brancato
Luis Carrasco Cabrera
Lucien Ferreira
German Giner
Luna Greco
Samira Jarrah
Aija Kazocina
Renata Leuschner
Jose Oriol Magrans
Ileana Miron
Stefanie Nave
Ragnor Pedersen
Hermine Reich
Silvia Ruocco
Miguel Santos
Alessia Pia Scarlato
Anne Theobald
Benedicte Vagenende
Alessia Verani

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Luxembourg Industries (Pamol) Ltd submitted a request to the competent national authority in Spain to modify the existing maximum residue levels (MRLs) for fosetyl/phosphonic acid (fosetyl-Al (sum of fosetyl, phosphonic acid and their salts, expressed as fosetyl)) in citrus fruits. Adequate analytical methods for enforcement are available to control the residues of potassium phosphonates according to the existing and proposed residue definitions for enforcement in the commodities under consideration. Since EFSA raised concerns regarding the independence of some of the residue trials submitted in support of the MRL application, EFSA presented three options of MRL proposals for further risk management consideration. Based on the risk assessment results, EFSA concluded that the short-term and long-term intake of residues resulting from the use of potassium phosphonates on citrus crops according to the reported agricultural practices is unlikely to present a risk to consumer health.

Indexed as

citrus fruitsconsumer risk assessmentfosetylfungicideMRLphosphonic acidpotassium phosphonates

Identifiers

PMID34795799
PMCPMC8579858
OpenAlexW3211685871

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.